Re:Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant...
by throwawayboise on Friday November 26, 2021 @05:50PM
(#29355075)
It's like the ideal scenario if you are a multinational pharmaceutical company.
[ Parent
| on HN ]
There are no comments on this comment yet.